No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
BRSP BrightSpire Capital
- 6.330
- -0.070-1.09%
Close Apr 25 16:00 ET
- 6.250
- -0.080-1.26%
Post 16:34 ET
826.93MMarket Cap-52750P/E (TTM)
6.355High6.300Low509.46KVolume6.310Open6.400Pre Close3.22MTurnover0.44%Turnover RatioLossP/E (Static)130.64MShares7.58052wk High0.65P/B740.17MFloat Cap4.63452wk Low0.80Dividend TTM116.93MShs Float14.138Historical High12.64%Div YieldTTM0.86%Amplitude1.752Historical Low6.323Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | NYSE Order Imbalance 51661.0 Shares on Buy Side 51661.0 Shares on Buy Side
Express News | NYSE Order Imbalance 70339.0 Shares on Sell Side 70339.0 Shares on Sell Side
Barclays Sticks to Their Hold Rating for BrightSpire Capital (BRSP)
BrightSpire Capital, Inc. Announces First Quarter 2024 Earnings Release and Conference Call Date
BrightSpire Capital, Inc. (NYSE:BRSP) ("BrightSpire Capital" or the "Company") today announced it will release first quarter 2024 financial results before the market opens on Wednesday, May 1, 2024. The Company will
Have Insiders Sold BrightSpire Capital Shares Recently?
We'd be surprised if BrightSpire Capital, Inc. (NYSE:BRSP) shareholders haven't noticed that the Executive VP, David Palame, recently sold US$338k worth of stock at US$6.76 per share. That sale was
BrightSpire Capital(BRSP.US) Officer Sells US$338K in Common Stock
$BrightSpire Capital(BRSP.US)$ Officer Palame David A sold 50,000 shares of Common Stock on Mar 27, 2024 at an average price of $6.76 for a total value of $338K.Source: Announcement What is statement
Comments
Despite a 5.3% return over the past year, the company's falling revenue and loss-making status pose investment risks. There are 4 warning signs despite some signs of improvement.
Shareholders in BrightSpire Capital (NYSE:BRSP) Have Lost 36%, as Stock Drops 8.7% This Past WeekConcerns about the company's profitability and revenue growth have led to a sharp decline in its stock value. Despite dividend-boosted TSR, long-term shareholders incur losses. Significant improvements in key metrics may stir investor interest in the stock.
1
ColumnsToday's Pre-Market Stock Movers: TSLA, F, KORE, AMLX and More
Gapping up
In reaction to earnings/guidance:
$RPM International(RPM.US$ +2.4%
Other news:
$Radiant Logistics(RLGT.US$ +6.8% (to restate FY21 earnings)
$Stellus Capital Investment(SCM.US$ +3.3% (declares Q4 dividends of $0.34 per share)
$Golden Ocean(GOGL.US$ +2.5% (authorizes new $100 mln share repurchase program)
$iPath Series B S&P 500 VIX Short-Term Futures ETN(VXX.US$ +1.5% (rising with pull back in stock futures)
$Pebblebrook Hotel Trust(PEB.US$ +1.3% (se...
In reaction to earnings/guidance:
$RPM International(RPM.US$ +2.4%
Other news:
$Radiant Logistics(RLGT.US$ +6.8% (to restate FY21 earnings)
$Stellus Capital Investment(SCM.US$ +3.3% (declares Q4 dividends of $0.34 per share)
$Golden Ocean(GOGL.US$ +2.5% (authorizes new $100 mln share repurchase program)
$iPath Series B S&P 500 VIX Short-Term Futures ETN(VXX.US$ +1.5% (rising with pull back in stock futures)
$Pebblebrook Hotel Trust(PEB.US$ +1.3% (se...
14
1
ColumnsToday's pre-market stock movers: KR, REV, RACE, PHG and more
Gainers:
• $Akero Therapeutics(AKRO.US$ +9.6% (announces two financing transactions with Pfizer (PFE) and Hercules Capital (HTGC) providing access to up to $125 million)
• $BrightSpire Capital(BRSP.US$ +6.3% (increases dividend)
• $Humanigen(HGEN.US$ +4% (entered into an agreement with PCI Pharma Services as part of preparations for commercialization in the United Kingdom)
• $Allison Transmission(ALSN.US$ +2.8% (electric hybrid bu...
• $Akero Therapeutics(AKRO.US$ +9.6% (announces two financing transactions with Pfizer (PFE) and Hercules Capital (HTGC) providing access to up to $125 million)
• $BrightSpire Capital(BRSP.US$ +6.3% (increases dividend)
• $Humanigen(HGEN.US$ +4% (entered into an agreement with PCI Pharma Services as part of preparations for commercialization in the United Kingdom)
• $Allison Transmission(ALSN.US$ +2.8% (electric hybrid bu...
11
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg